Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Clinical trial NCT06254560 · RECRUITING
Trial details
- NCT number
- NCT06254560
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2026-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.